GPX4 and glioblastoma: In the study of glioblastoma, RSL3 inhibits the activity of GPX4, drives the occurrence of ferrozois and induces oxidative death of glioblastoma cells, providing new therapeutic ideas for glioblastoma (Li et al., 2021).